News

Filter

Current filters:

BioMerieux

FDA approves two GSK melanoma drugs and bioMerieux companion diagnostic

30-05-2013

The US Food and Drug Administration yesterday (May 29) approved two new oral drugs from UK pharma giant…

BioMerieuxdabrafenibGlaxoSmithKlineMekinistNorth AmericaOncologyPharmaceuticalRegulationTafinlartrametinib

M&A briefs: Hainan Haiyao to take stake in SinoMab; bioMerieux partners with Quanaterix

19-11-2012

China's Hainan Haiyao Co has signed a letter of intent with Creator Investment and Good Catch Investments…

BioMerieuxHainan HaiyaoHudson BiopharmaLicensingMergers & AcquisitionsPharmaceuticalQuanterixSinoMab Bioscience

bioMerieux partners with Biocartis on molecular diagnostics; takes equity stake

09-11-2010

French firm bioMerieux (Euronext: BIM) and privately-held Biocartis of Switzerland have entered into…

BiocartisBioMerieuxLicensingPharmaceuticalResearch

BioMerieux enters strategic partnership with Knome, including equity stake; posts strong sales growth

22-04-2010

France’s bioMerieux and USA-based Knome have entered into a strategic agreement to collaborate in…

BioMerieuxFinancialKnomeLicensingMergers & AcquisitionsPharmaceutical

Back to top